{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T23:03:12Z","timestamp":1778713392822,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.nbd.2013.10.006","type":"journal-article","created":{"date-parts":[[2013,10,10]],"date-time":"2013-10-10T13:04:43Z","timestamp":1381410283000},"page":"72-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Discovery of novel anxiolytic agents \u2014 The trials and tribulations of pre-clinical models of anxiety"],"prefix":"10.1016","volume":"61","author":[{"given":"N.A.","family":"Andrews","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Papakosta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.M.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2013.10.006_bb0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF02247359","article-title":"Increased 5-HT release mediates the anxiogenic response during benzodiazepine withdrawal: a review of supporting neurochemical and behavioural evidence","volume":"112","author":"Andrews","year":"1993","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.nbd.2013.10.006_bb9010","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0014-2999(93)90827-5","article-title":"Handling history of rats modifies behavioural effects of drugs in the elevated plus-maze test of anxiety","volume":"235","author":"Andrews","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2013.10.006_bb0005","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0028-3908(71)90074-8","article-title":"Evaluation of a rapid technique for detecting minor tranquilizers","volume":"10","author":"Aron","year":"1971","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2013.10.006_bb0015","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0022-3565(25)24321-X","article-title":"Behavioral studies with anxiolytic drugs. III. Antipunishment actions of buspirone in the pigeon do not involve benzodiazepine receptor mechanisms","volume":"238","author":"Barrett","year":"1986","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2013.10.006_bb0020","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0149-7634(96)00062-0","article-title":"Differentiation of anxiolytic and panicolytic drugs by effects on rat and mouse defense test batteries","volume":"21","author":"Blanchard","year":"1997","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.nbd.2013.10.006_bb0025","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0149-7634(01)00009-4","article-title":"Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic","volume":"25","author":"Blanchard","year":"2001","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.nbd.2013.10.006_bb0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-2999(03)01274-3","article-title":"The mouse light\/dark box test","volume":"463","author":"Bourin","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2013.10.006_bb0035","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0304-3940(94)90801-X","article-title":"Paradoxical differences in animal models of anxiety among the Roman rat lines","volume":"182","author":"Chaouloff","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2013.10.006_bb0040","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0149-7634(01)00011-2","article-title":"A detailed ethological analysis of the mouse open field test: effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field","volume":"25","author":"Choleris","year":"2001","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.nbd.2013.10.006_bb0045","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0091-3057(80)90067-2","article-title":"Preliminary report of a simple animal behaviour for the anxiolytic effects of benzodiazepines","volume":"13","author":"Crawley","year":"1980","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.nbd.2013.10.006_bb0050","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1476-5381.2011.01362.x","article-title":"The age of anxiety: role of animal models of anxiolytic action in drug discovery","volume":"164","author":"Cryan","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2013.10.006_bb0055","first-page":"235","article-title":"Pharmacological analysis of fear-potentiated startle","volume":"26","author":"Davis","year":"1993","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"51","key":"10.1016\/j.nbd.2013.10.006_bb0060","doi-asserted-by":"crossref","DOI":"10.3791\/2613","article-title":"Hyponeophagia: a measure of anxiety in the mouse","volume":"17","author":"Deacon","year":"2011","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.nbd.2013.10.006_bb0065","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF02244419","article-title":"One-trial tolerance to the anxiolytic effects of chlordiazepoxide in the plus-maze","volume":"100","author":"File","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.nbd.2013.10.006_bb0070","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0166-4328(01)00292-3","article-title":"Factors controlling measures of anxiety and responses to novelty in the mouse","volume":"125","author":"File","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2013.10.006_bb0090","first-page":"97","article-title":"Benzodiazepine withdrawal: behavioural pharmacology and neurochemical changes","volume":"59","author":"File","year":"1993","journal-title":"Biochem. Soc. Symp."},{"key":"10.1016\/j.nbd.2013.10.006_bb0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1476-5381.1978.tb07001.x","article-title":"Can social interaction be used to measure anxiety?","volume":"62","author":"File","year":"1978","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2013.10.006_bb0080","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0091-3057(79)90298-3","article-title":"A test of anxiety that distinguishes between the actions of benzodiazepines and those of other minor tranquilisers and of stimulants","volume":"11","author":"File","year":"1979","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.nbd.2013.10.006_bb0085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0014-2999(03)01273-1","article-title":"A review of 25years of the social interaction test","volume":"463","author":"File","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2013.10.006_bb0095","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1523\/JNEUROSCI.16-15-04810.1996","article-title":"Comparative study of pre- and postsynaptic 5-HT1A receptor modulation of anxiety in two ethological animal tests","volume":"16","author":"File","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2013.10.006_bb0100","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/BF00429273","article-title":"The effects of meprobamate, barbiturate, Damphetamine and promazine on experimentally induced conflict in the rat","volume":"1","author":"Geller","year":"1960","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.nbd.2013.10.006_bb0105","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00213-009-1479-6","article-title":"Differential effects of MPEP and diazepam in tests of conditioned emotional response and Pavlovian-to-instrumental transfer suggests \u2018anxiolytic\u2019 effects are mediated by different mechanisms","volume":"204","author":"George","year":"2009","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.nbd.2013.10.006_bb0110","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0149-7634(98)00024-4","article-title":"The elevated T-maze as an experimental model of anxiety","volume":"23","author":"Graeff","year":"1998","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.nbd.2013.10.006_bb9005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00504983","article-title":"Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behaviour","volume":"327","author":"Handley","year":"1984","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.nbd.2013.10.006_bb0115","series-title":"The Four-Plate Test in Mice","first-page":"123","article-title":"Mood and Anxiety Related Phenotypes in Mice","volume":"vol. 63","author":"Hascoet","year":"2011"},{"key":"10.1016\/j.nbd.2013.10.006_bb0120","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0091-3057(95)02126-4","article-title":"A review of the validity and variability of the elevated plus-maze as an animal model of anxiety","volume":"54","author":"Hogg","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.nbd.2013.10.006_bb9000","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/eji.201142048","article-title":"The need for littermate controls","volume":"42","author":"Holmdahl","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.nbd.2013.10.006_bb0130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1017\/S1121189X00001421","article-title":"The global burden of mental disorders: an update from the WHO World Mental Health (WMH) surveys","volume":"18","author":"Kessler","year":"2009","journal-title":"Epidemiol. Psichiatr. Soc."},{"key":"10.1016\/j.nbd.2013.10.006_bb0125","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/jgm.1473","article-title":"NC3Rs reporting guidelines working group. Animal research: reporting in vivo experiments: the ARRIVE guidelines","volume":"12","author":"Kilkenny","year":"2010","journal-title":"J. Gene Med."},{"key":"10.1016\/j.nbd.2013.10.006_bb0135","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.bbr.2011.04.025","article-title":"The structural and functional connectivity of the amygdala: from normal emotion to pathological anxiety","volume":"223","author":"Kim","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2013.10.006_bb0140","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0091-3057(00)00415-9","article-title":"Selective breeding of 5-HT(1A) receptor-mediated responses: application to emotion and receptor action","volume":"67","author":"Knapp","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.nbd.2013.10.006_bb0145","article-title":"Elevated plus maze for mice","volume":"22","author":"Komada","year":"2008","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.nbd.2013.10.006_bb0150","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/da.21922","article-title":"Toward an account of clinical anxiety predicated on basic, neurally mapped mechanisms of Pavlovian fear-learning: the case for conditioned overgeneralization","volume":"29","author":"Lissek","year":"2012","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.nbd.2013.10.006_bb0155","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nrn3492","article-title":"The contextual brain: implications for fear conditioning, extinction and psychopathology","volume":"14","author":"Maren","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2013.10.006_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpsychires.2011.03.006","article-title":"Gender differences in anxiety disorders: prevalence, course of illness, comorbidity and burden of illness","author":"McLean","year":"2011","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.nbd.2013.10.006_bb0165","doi-asserted-by":"crossref","first-page":"10387","DOI":"10.1523\/JNEUROSCI.1219-06.2006","article-title":"Bombesin receptors as a novel anti-anxiety therapeutic target: BB1 receptor actions on anxiety through alterations of serotonin activity","volume":"26","author":"Merali","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2013.10.006_bb0170","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00213-008-1118-7","article-title":"Effects of gastrin-releasing peptide agonist and antagonist administered to the basolateral nucleus of the amygdala on conditioned fear in the rat","volume":"200","author":"Mountney","year":"2008","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.nbd.2013.10.006_bb0175","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neubiorev.2006.04.002","article-title":"Susceptibility genes for schizophrenia: characterisation of mutant mouse models at the level of phenotypic behaviour","volume":"31","author":"O'Tuathaigh","year":"2007","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.nbd.2013.10.006_bb0180","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","article-title":"Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat","volume":"14","author":"Pellow","year":"1985","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.nbd.2013.10.006_bb0185","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1037\/h0077494","article-title":"Burying as a defensive response in rats","volume":"92","author":"Pinel","year":"1978","journal-title":"J. Comp. Physiol. Psychol."},{"key":"10.1016\/j.nbd.2013.10.006_bb0190","series-title":"Encyclopedia of Behavioral Neuroscience","first-page":"90","article-title":"Animal Tests for Anxiety","author":"Rodgers","year":"2010"},{"key":"10.1016\/j.nbd.2013.10.006_bb0195","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1590\/S0100-879X1997000300002","article-title":"Animal models of anxiety: an ethological perspective","volume":"30","author":"Rodgers","year":"1997","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.nbd.2013.10.006_bb0200","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1046\/j.1460-9568.2003.02548.x","article-title":"One-trial sensitization' to the anxiolytic-like effects of cannabinoid receptor antagonist SR141716A in the mouse elevated plus-maze","volume":"17","author":"Rodgers","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2013.10.006_bb0205","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0165-0270(94)00173-E","article-title":"Automation of the social interaction test by a video-tracking system: behavioural effects of repeated phencyclidine treatment","volume":"59","author":"Sams-Dodd","year":"1995","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.nbd.2013.10.006_bb0210","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/BF02244871","article-title":"Behavioural and pharmacological characterisation of the elevated \u201czero-maze\u201d as an animal model of anxiety","volume":"116","author":"Shepherd","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.nbd.2013.10.006_bb0215","first-page":"104","article-title":"Light\/dark transition test for mice","volume":"13","author":"Takao","year":"2006","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.nbd.2013.10.006_bb0220","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0091-3057(99)00261-0","article-title":"Behavioral effects of acute and chronic imipramine in the elevated T-maze model of anxiety","volume":"65","author":"Teixeira","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.nbd.2013.10.006_bb0225","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0091-3057(81)90219-7","article-title":"Conditioned defensive burying: a new paradigm for the study of anxiolytic agents","volume":"15","author":"Treit","year":"1981","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.nbd.2013.10.006_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00403989","article-title":"A simple and reliable conflict procedure for testing anti-anxiety agents","volume":"21","author":"Vogel","year":"1971","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.nbd.2013.10.006_bb0235","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0361-9230(92)90072-6","article-title":"Behavioral consequences in animal tests of anxiety and exploration of exposure to cat odor","volume":"29","author":"Zangrossi","year":"1992","journal-title":"Brain Res. Bull."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996113002799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996113002799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T16:25:21Z","timestamp":1746030321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996113002799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":50,"alternative-id":["S0969996113002799"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2013.10.006","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel anxiolytic agents \u2014 The trials and tribulations of pre-clinical models of anxiety","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2013.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}